Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 17.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 312,387 shares of the pharmacy operator’s stock after selling 63,784 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Walgreens Boots Alliance were worth $8,156,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of WBA. Teacher Retirement System of Texas boosted its position in Walgreens Boots Alliance by 2.5% in the third quarter. Teacher Retirement System of Texas now owns 56,860 shares of the pharmacy operator’s stock valued at $1,265,000 after buying an additional 1,400 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its position in Walgreens Boots Alliance by 17.2% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 17,718 shares of the pharmacy operator’s stock valued at $394,000 after buying an additional 2,605 shares during the last quarter. Nomura Asset Management Co. Ltd. boosted its position in Walgreens Boots Alliance by 19.7% in the third quarter. Nomura Asset Management Co. Ltd. now owns 1,126,151 shares of the pharmacy operator’s stock valued at $25,046,000 after buying an additional 185,474 shares during the last quarter. Signaturefd LLC boosted its position in Walgreens Boots Alliance by 39.1% in the third quarter. Signaturefd LLC now owns 14,043 shares of the pharmacy operator’s stock valued at $312,000 after buying an additional 3,946 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.2 %

Shares of WBA opened at $15.95 on Friday. The firm has a market cap of $13.76 billion, a P/E ratio of -2.28, a price-to-earnings-growth ratio of 1.02 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 12-month low of $15.89 and a 12-month high of $32.89. The company’s 50-day moving average price is $18.56 and its 200 day moving average price is $21.20. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.16 EPS. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.27%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is presently -14.29%.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on WBA shares. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. UBS Group lowered their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. TD Cowen lowered their price objective on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research report on Wednesday, April 3rd. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $24.36.

Read Our Latest Report on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Articles

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.